AML-109 Preliminary Results of MT-401 in Post-Transplant Measurable Residual Disease Positive (MRD+) Acute Myeloid Leukemia (AML) Patients

Shukaib Arslan, Jingmei Hsu, Betul Oran, Alejandro Sica, Hongtao Liu, Margarida Silverman, Nelli Bejanyan, Antonio DiStasi, Robin McCallum, Silvia Quintero, Gerald Garrett, Karrie Wang, Eric Smith, Tsvetelina Hoang, Tara Shahim, Jeannette Crisostomo, Anna Wilga-Savitski, Jennifer Pickering, Laura Angelo, Anastasiya SmithJuan Vera, Mythili Koneru

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'AML-109 Preliminary Results of MT-401 in Post-Transplant Measurable Residual Disease Positive (MRD+) Acute Myeloid Leukemia (AML) Patients'. Together they form a unique fingerprint.

Medicine & Life Sciences